Wu Y Q, Handwerger S
Department of Pediatrics and Cell Biology, Duke University Medical Center, Durham, North Carolina 27710.
Endocrinology. 1992 Dec;131(6):2935-40. doi: 10.1210/endo.131.6.1332852.
Previous studies from our laboratory have demonstrated that high density lipoprotein (HDL) HDL and apolipoprotein-AI (apoAI) stimulate human placental lactogen (hPL) release from human trophoblast cells. To determine whether protein kinase-C (PKC) activation is involved in the mechanism of HDL- and apoAI-mediated hPL release, we examined the effects of these factors on the phosphorylation of cytosolic proteins known to be phosphorylated in response to PKC activation by phorbol myristate acetate (PMA). HDL and apoAI each caused a dose- and time-dependent increase in phosphorylation of a PMA-inducible 80K mol wt acidic cytosolic protein in a manner similar to that observed in many other cell types. Stimulation of 80K protein phosphorylation was apparent 5 min after the addition of HDL, apoAI, or PMA and was maximal at 15 min. Maximal 80K protein phosphorylation in cells exposed to PMA (1.6 microM), HDL (1500 micrograms/ml), and apoAI (600 micrograms/ml) was 284%, 206%, and 239% that in untreated cells, respectively. The increase in both 80K protein phosphorylation and hPL release in response to apoAI was prevented by pretreatment of the cells with the PKC inhibitor staurosporine (10 microM) or by down-regulation of PKC after extended preincubation of the cells with 16 microM PMA. (Bu)2cAMP and the adenylate cyclase activator forskolin, which stimulate hPL release, had no effect on 80K protein phosphorylation. These results strongly suggest that HDL- and apoAI-stimulated hPL release involves a PKC-dependent pathway. Since earlier studies also implicate a cAMP-mediated pathway in the stimulation of hPL release by these agents, it appears that multiple intracellular pathways are involved in the stimulation of hPL release.
我们实验室之前的研究表明,高密度脂蛋白(HDL)和载脂蛋白 - AI(apoAI)可刺激人滋养层细胞释放人胎盘催乳素(hPL)。为了确定蛋白激酶 - C(PKC)激活是否参与HDL和apoAI介导的hPL释放机制,我们研究了这些因子对已知可因佛波酯肉豆蔻酸酯乙酸酯(PMA)激活PKC而发生磷酸化的胞质蛋白磷酸化的影响。HDL和apoAI各自均以剂量和时间依赖性方式增加了一种PMA诱导的80K道尔顿分子量的酸性胞质蛋白的磷酸化,其方式与在许多其他细胞类型中观察到的相似。添加HDL、apoAI或PMA后5分钟,80K蛋白磷酸化的刺激作用明显,15分钟时达到最大值。暴露于PMA(1.6 microM)、HDL(1500微克/毫升)和apoAI(600微克/毫升)的细胞中,80K蛋白磷酸化的最大值分别是未处理细胞的284%、206%和239%。用PKC抑制剂星形孢菌素(10 microM)预处理细胞,或在用16 microM PMA长时间预孵育细胞后下调PKC,均可阻止apoAI诱导的80K蛋白磷酸化和hPL释放增加。刺激hPL释放的(Bu)2cAMP和腺苷酸环化酶激活剂福斯可林对80K蛋白磷酸化无影响。这些结果强烈表明,HDL和apoAI刺激的hPL释放涉及PKC依赖性途径。由于早期研究也表明这些因子刺激hPL释放涉及cAMP介导的途径,因此似乎多种细胞内途径参与了hPL释放的刺激过程。